Akcea Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAkcea Therapeutics

Akcea Therapeutics(AKCA)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Tegsedi	Inotersen	2018-10-05	2025-2031	Amyloidosis , Familial amyloid neuropathies
Waylivra	Volanesorsen	2019-05-03		Hyperlipoproteinemia type i

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

cardiovascular abnormalities

,

hyperlipoproteinemia type i

,

,

hyperlipidemias

,

hyperlipoproteinemia type v

,

hyperlipoproteinemias

,

,

familial partial lipodystrophy

,

hypertriglyceridemia

,

familial amyloid neuropathies

,

Sodium chloride

,

pulmonary hypertension

,

,

,

,

,

brain hypoxia-ischemia

,

necrotizing enterocolitis

,

,

,

,

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

,

pulmonary edema

,

squamous cell carcinoma

,

squamous cell neoplasms

,

prostatic neoplasms

,

breast neoplasms

,

,

,

ovarian neoplasms

,

acquired immunodeficiency syndrome

,

communicable diseases

,

,

,

,

premature obstetric labor

,

,

,

,

,

ovarian epithelial carcinoma

,

overactive urinary bladder

,

non-small-cell lung carcinoma

,

chronic renal insufficiency

,

kidney diseases

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

,

,

head and neck neoplasms

,

renal cell carcinoma

,

,

urinary tract infections

,

non-hodgkin lymphoma

,

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

erectile dysfunction

,

,

,

muscle spasticity

,

urinary incontinence

,

,

,

postmenopausal osteoporosis

,

stomach neoplasms

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

acute coronary syndrome

,

,

parkinson disease

,

human influenza

,

,

,

brain neoplasms

,

neoplasm metastasis

,

small cell lung carcinoma

,

,

venous thrombosis

,

thrombophlebitis

,

,

postoperative nausea and vomiting

,

post-traumatic stress disorders

,

traumatic stress disorders

,

,

,

,

triple negative breast neoplasms

,

endometrial neoplasms

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

immunologic deficiency syndromes

,

uterine cervical neoplasms

,

atherosclerosis

,

,

,

b-cell lymphoma

,

systemic lupus erythematosus

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

renal insufficiency

,

cardiovascular diseases

,

hyperlipidemias

,

hyperlipoproteinemias

hypertriglyceridemia

,

hypercholesterolemia

,

hyperlipoproteinemia type ii

,

,

familial partial lipodystrophy

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

non-alcoholic fatty liver disease

,

,

hyperlipidemias

,

hyperlipoproteinemia type v

,

,

hyperlipoproteinemia type i

,

hyperlipoproteinemias

,

homozygous familial hypercholesterolemia

renal cell carcinoma

,

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

hepatocellular carcinoma

,

stomach neoplasms

,

,

liver neoplasms

,

,

gastrointestinal neoplasms

,

female genital neoplasms

,

neuroendocrine tumors

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

breast neoplasms

healthy volunteers/patients

cardiovascular diseases

,

hyperlipidemias

,

hyperlipoproteinemias

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use